BUSINESS SEGMENT INFORMATION
 12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
BUSINESS SEGMENT INFORMATION

NOTE 10 – BUSINESS SEGMENT INFORMATION

 

As of December 31, 2021, the Company operated in two reportable segments (Corporate and Health Supplements) supported by a corporate group which conducts activities that are non-segment specific. The following table presents selected financial information about the Company’s reportable segments for the Year ended December 31, 2021. 

 

  

   CONSOLIDATED   HEALTH SUPPLEMENTS   CORPORATE 
       BergaMet   UBN     
Revenue   1,676,598    1,676,598    —    — 
Less Selling Fees   (210,816)   (210,816)          
Cost of Revenue   770,704    770,704    —    — 
Long-lived Assets   715,140    212,413    502,727    — 
Gain (Loss) Before Income Tax   (1,975,971)   (701,833)   (136,308)   (1,137,830)
Identifiable Assets   2,092,341    2,092,341    —    — 
Depreciation and Amortization   5,100    5,100    —    — 

 

As of December 31, 2021, the Company operated in two reportable segments (Corporate and Health Supplements) supported by a corporate group which conducts activities that are non-segment specific. The following table presents selected financial information about the Company’s reportable segments for the Quarter ended December 31, 2021.

 

   CONSOLIDATED   HEALTH SUPPLEMENTS   CORPORATE 
       BergaMet   UBN     
Revenue   766,372    766,372    —    — 
Less Selling Fees   (94,783)   (94,783)          
Cost of Revenue   623,248    623,248    —    — 
Long-lived Assets   715,140    212,413    502,727    — 
Gain (Loss) Before Income Tax   (1,975,971)   (701,833)   (136,308)   (1,137,830)
Identifiable Assets   2,092,341    2,092,341    —    — 
Depreciation and Amortization   1,275    1,275    —    —